LIN | ||
---|---|---|
OUTLOOK RATING 1..100 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 7 | |
SMR RATING 1..100 | 50 | |
PRICE GROWTH RATING 1..100 | 38 | |
P/E GROWTH RATING 1..100 | 54 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GLOV | LIN | |
---|---|---|
RSI ODDS (%) | 1 day ago76% | N/A |
Stochastic ODDS (%) | 1 day ago81% | 1 day ago43% |
Momentum ODDS (%) | 1 day ago68% | 1 day ago47% |
MACD ODDS (%) | 1 day ago70% | 1 day ago69% |
TrendWeek ODDS (%) | 1 day ago83% | 1 day ago52% |
TrendMonth ODDS (%) | 1 day ago82% | 1 day ago44% |
Advances ODDS (%) | 18 days ago83% | 3 days ago51% |
Declines ODDS (%) | 8 days ago65% | 8 days ago46% |
BollingerBands ODDS (%) | 1 day ago88% | N/A |
Aroon ODDS (%) | 1 day ago75% | 1 day ago44% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BHK | 9.70 | N/A | N/A |
Blackrock Core BD TR | |||
IEI | 118.93 | -0.07 | -0.06% |
iShares 3-7 Year Treasury Bond ETF | |||
AAA | 24.97 | -0.02 | -0.08% |
Alternative AccessFirstPriorityCLO BdETF | |||
CWS | 68.09 | -0.32 | -0.47% |
AdvisorShares Focused Equity ETF | |||
THNR | 21.91 | -0.88 | -3.87% |
Amplify Weight Loss Drug & Treatment ETF |
A.I.dvisor indicates that over the last year, GLOV has been closely correlated with MCO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLOV jumps, then MCO could also see price increases.
Ticker / NAME | Correlation To GLOV | 1D Price Change % | ||
---|---|---|---|---|
GLOV | 100% | -0.17% | ||
MCO - GLOV | 77% Closely correlated | -0.66% | ||
BN - GLOV | 76% Closely correlated | -3.84% | ||
LIN - GLOV | 76% Closely correlated | -0.43% | ||
ROP - GLOV | 74% Closely correlated | -0.23% | ||
MFC - GLOV | 74% Closely correlated | -3.81% | ||
More |